These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 37268199)

  • 1. N-methylpiperazine-diepoxyovatodiolide ameliorates peritoneal fibrosis via suppressing TGF-β/Smad and JAK/STAT signaling pathway.
    Mo M; Zeng Y; Zeng Y; Li S; He X; Chen X; Luo Q; Liu M; Luo C; Dou X; Peng F; Long H
    Chem Biol Interact; 2023 Sep; 382():110589. PubMed ID: 37268199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parthenolide, an NF-κB inhibitor, alleviates peritoneal fibrosis by suppressing the TGF-β/Smad pathway.
    Zhang Y; Huang Q; Chen Y; Peng X; Wang Y; Li S; Wu J; Luo C; Gong W; Yin B; Xiao J; Zhou W; Peng F; Long H
    Int Immunopharmacol; 2020 Jan; 78():106064. PubMed ID: 31838448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigating the therapeutic effects and mechanisms of Roxadustat on peritoneal fibrosis Based on the TGF-β/Smad pathway.
    Wang L; Fan J; Yang T; Shen J; Wang L; Ge W
    Biochem Biophys Res Commun; 2024 Jan; 693():149387. PubMed ID: 38145606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parthenolide alleviates peritoneal fibrosis by inhibiting inflammation via the NF-κB/ TGF-β/Smad signaling axis.
    Zhang Y; Feng W; Peng X; Zhu L; Wang Z; Shen H; Chen C; Xiao L; Li S; Zhao Y; Lin M; Huang Y; Long H; Liang J
    Lab Invest; 2022 Dec; 102(12):1346-1354. PubMed ID: 36307537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Silymarin ameliorates peritoneal fibrosis by inhibiting the TGF-β/Smad signaling pathway.
    Bai Y; Wang L; TingYang ; Wang L; Ge W
    Naunyn Schmiedebergs Arch Pharmacol; 2023 Oct; 396(10):2379-2391. PubMed ID: 37052642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TMT quantitative proteomics and network pharmacology reveal the mechanism by which asiaticoside regulates the JAK2/STAT3 signaling pathway to inhibit peritoneal fibrosis.
    Sun J; Tang L; Shan Y; Yu M; Sheng L; Huang L; Cao H; Dai H; Wang F; Zhao J; Sheng M
    J Ethnopharmacol; 2023 Jun; 309():116343. PubMed ID: 36906159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Curcumin ameliorates peritoneal fibrosis via inhibition of transforming growth factor-activated kinase 1 (TAK1) pathway in a rat model of peritoneal dialysis.
    Zhao JL; Zhang T; Shao X; Zhu JJ; Guo MZ
    BMC Complement Altern Med; 2019 Oct; 19(1):280. PubMed ID: 31647008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Empagliflozin, a sodium glucose cotransporter-2 inhibitor, ameliorates peritoneal fibrosis via suppressing TGF-β/Smad signaling.
    Shentu Y; Li Y; Xie S; Jiang H; Sun S; Lin R; Chen C; Bai Y; Zhang Y; Zheng C; Zhou Y
    Int Immunopharmacol; 2021 Apr; 93():107374. PubMed ID: 33517222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-fibrotic effects of valproic acid in experimental peritoneal fibrosis.
    Costalonga EC; de Freitas LJ; Aragone DDSP; Silva FMO; Noronha IL
    PLoS One; 2017; 12(9):e0184302. PubMed ID: 28873458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Curcumin suppresses epithelial-to-mesenchymal transition of peritoneal mesothelial cells (HMrSV5) through regulation of transforming growth factor-activated kinase 1 (TAK1).
    Zhao JL; Guo MZ; Zhu JJ; Zhang T; Min DY
    Cell Mol Biol Lett; 2019; 24():32. PubMed ID: 31143210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BMSC-derived Exosomes Ameliorate Peritoneal Dialysis-associated Peritoneal Fibrosis via the Mir-27a-3p/TP53 Pathway.
    Zhao JL; Zhao L; Zhan QN; Liu M; Zhang T; Chu WW
    Curr Med Sci; 2024 Apr; 44(2):333-345. PubMed ID: 38622424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Asiaticoside inhibits TGF-β1-induced mesothelial-mesenchymal transition and oxidative stress via the Nrf2/HO-1 signaling pathway in the human peritoneal mesothelial cell line HMrSV5.
    Zhao J; Shi J; Shan Y; Yu M; Zhu X; Zhu Y; Liu L; Sheng M
    Cell Mol Biol Lett; 2020; 25():33. PubMed ID: 32514269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-122-5p promotes peritoneal fibrosis in a rat model of peritoneal dialysis by targeting Smad5 to activate Wnt/β-catenin pathway.
    Liu Y; Ma Z; Huang Z; Zou D; Li J; Feng P
    Ren Fail; 2022 Dec; 44(1):191-203. PubMed ID: 35170385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of STAT3 Signaling in High Glucose-Induced Epithelial Mesenchymal Transition in Human Peritoneal Mesothelial Cell Line HMrSV5.
    Zhang P; Dai H; Peng L
    Kidney Blood Press Res; 2019; 44(2):179-187. PubMed ID: 30943519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LCZ696, an angiotensin receptor-neprilysin inhibitor, ameliorates epithelial-mesenchymal transition of peritoneal mesothelial cells and M2 macrophage polarization.
    Hu Y; Zhou C; Zhong Q; Li X; Li J; Shi Y; Ma X; Jiang D; Wang Y; Zhuang S; Liu N
    Ren Fail; 2024 Dec; 46(2):2392849. PubMed ID: 39165231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autophagy promotes fibrosis and apoptosis in the peritoneum during long-term peritoneal dialysis.
    Wu J; Xing C; Zhang L; Mao H; Chen X; Liang M; Wang F; Ren H; Cui H; Jiang A; Wang Z; Zou M; Ji Y
    J Cell Mol Med; 2018 Feb; 22(2):1190-1201. PubMed ID: 29077259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and significance of SIRT6 in human peritoneal dialysis effluents and peritoneal mesothelial cells.
    Shi SS; Zhang YQ; Zhang LQ; Li YF; Zhou XS; Li RS
    Int Urol Nephrol; 2024 Aug; 56(8):2659-2670. PubMed ID: 38483736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesenchymal stem cells ameliorate experimental peritoneal fibrosis by suppressing inflammation and inhibiting TGF-β1 signaling.
    Ueno T; Nakashima A; Doi S; Kawamoto T; Honda K; Yokoyama Y; Doi T; Higashi Y; Yorioka N; Kato Y; Kohno N; Masaki T
    Kidney Int; 2013 Aug; 84(2):297-307. PubMed ID: 23486522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated expression of HDAC6 in clinical peritoneal dialysis patients and its pathogenic role on peritoneal angiogenesis.
    Shi Y; Ni J; Tao M; Ma X; Wang Y; Zang X; Hu Y; Qiu A; Zhuang S; Liu N
    Ren Fail; 2020 Nov; 42(1):890-901. PubMed ID: 32862739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitro-oleic acid inhibits the high glucose-induced epithelial-mesenchymal transition in peritoneal mesothelial cells and attenuates peritoneal fibrosis.
    Su W; Wang H; Feng Z; Sun J
    Am J Physiol Renal Physiol; 2020 Feb; 318(2):F457-F467. PubMed ID: 31760768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.